ADMA

ADMA BIOLOGICS, INC.

ADMA · CIK 1368514 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$510M
20182025
Net Income$147M
20182025
Operating CF$50M
20182025
Free Cash Flow$28M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.5B$0.4B$0.3B$0.2B$0.1B$0.0B$0.0B$0.0B
Cost of Revenue$0.2B$0.2B$0.2B$0.1B$0.1B$0.1B$0.0B$0.0B
Gross Profit$0.3B$0.2B$0.1B$0.0B$0.0B——$-0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.1B$0.1B$0.1B$0.1B$0.0B———
Operating Income$0.2B$0.1B$0.0B$-0.0B$-0.1B$-0.1B$-0.0B$-0.0B
Net Income$0.1B$0.2B$-0.0B$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
EPS (Basic)$0.62$0.85$-0.13$-0.33$-0.51———
EPS (Diluted)$0.60$0.81$-0.13$-0.33$-0.51———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.6B$0.5B$0.3B$0.3B$0.3B$0.2B$0.1B$0.1B
Current Assets$0.5B$0.3B$0.3B$0.3B$0.2B$0.2B$0.1B$0.0B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
Total Liabilities$0.1B$0.1B$0.2B$0.2B$0.1B$0.1B$0.1B$0.1B
Current Liabilities$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.5B$0.3B$0.1B$0.2B$0.1B$0.1B$0.0B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.1B$0.1B$0.0B$-0.1B$-0.1B$-0.1B$-0.1B$-0.1B
Investing Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.1B$-0.0B$0.1B$0.1B$0.1B$0.1B$0.0B
← Companies